共 38 条
Efficient Biocatalytic System for Biosensing by Combining Metal- Organic Framework (MOF)-Based Nanozymes and G-Quadruplex (G4)-DNAzymes
被引:43
|作者:
Mao, Xuanxiang
[1
]
He, Fangni
[1
]
Qu, Dehui
[1
]
Wei, Shijiong
[1
]
Luo, Rengan
[1
]
Chen, Yun
[1
]
Zhang, Xiaobo
[1
]
Lei, Jianping
[1
]
Monchaud, David
[2
]
Mergny, Jean-Louis
[1
,3
]
Ju, Huangxian
[1
]
Zhou, Jun
[1
]
机构:
[1] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Analyt Chem Life Sci, Nanjing 210023, Peoples R China
[2] UBFC, CNRS UMR, Inst Chim Mol ICMUB, F-21078 Dijon, France
[3] Inst Polytech Paris, Lab Opt & Biosci, Ecole Polytech, CNRS,INSERM, F-91128 Palaiseau, France
基金:
中国博士后科学基金;
中国国家自然科学基金;
关键词:
PEROXIDASE-LIKE ACTIVITY;
DNAZYME ACTIVITY;
HEMIN DNAZYME;
NANOPARTICLES;
INSIGHTS;
ENZYME;
CHEMILUMINESCENT;
NANOMATERIALS;
CATALYSIS;
OXYGEN;
D O I:
10.1021/acs.analchem.2c00600
中图分类号:
O65 [分析化学];
学科分类号:
070302 ;
081704 ;
摘要:
ABSTRACT: A high catalytic efficiency associated with a robust chemical structure are among the ultimate goals when developing new biocatalytic systems for biosensing applications. To get ever closer to these goals, we report here on a combination of metal???organic framework (MOF)-based nanozymes and a G-quadruplex (G4)-based catalytic system known as G4-DNAzyme. This approach aims at combining the advantages of both partners (chiefly, the robustness of the former and the modularity of the latter). To this end, we used MIL-53(Fe) MOF and linked it covalently to a G4-forming sequence (F3TC), itself covalently linked to its cofactor hemin. The resulting complex (referred to as MIL-53(Fe)/G4-hemin) exhibited exquisite peroxidasemimicking oxidation activity and an excellent robustness (being stored in water for weeks). These properties were exploited to devise a new biosensing system based on a cascade of reactions catalyzed by the nanozyme (ABTS oxidation) and an enzyme, the alkaline phosphatase (or ALP, ascorbic acid 2phosphate dephosphorylation). The product of the latter poisoning the former, we thus designed a biosensor for ALP (a marker of bone diseases and cancers), with a very low limit of detection (LOD, 0.02 U L???1), which is operative in human plasma samples.
引用
收藏
页码:7295 / 7302
页数:8
相关论文